| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 177.932 | 82 |
| GSM780708 | Untreated after 4 days (C2_1) | 151.307 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 134.597 | 79 |
| GSM780719 | Untreated after 4 days (C1_2) | 165.47 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 173.209 | 82 |
| GSM780721 | Untreated after 4 days (C3_2) | 139.578 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 139.502 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 148.867 | 80 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 168.147 | 82 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 131.625 | 79 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 148.672 | 80 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 155.33 | 81 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 132.883 | 79 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 160.248 | 81 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 175.42 | 82 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 162.578 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 158.185 | 81 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 161.095 | 81 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 152.145 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 141.672 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 157.867 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 142.779 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 146.12 | 80 |